Atlas Venture Life Science Advisors

Venture Capital Exempt reporting adviser

Legal name: Atlas Venture Life Science Advisors, LLC

Cambridge, MA Website LinkedIn

AUM

$3.0B
Private fund assets

Private funds

8
Venture Capital 8

Private fund assets

$3.0B
Gross asset value

Employees

—

Last Form D raise

Sep 2025
Most recent fund filing

From SEC Form ADV filing (filed Mar 31, 2026). View on SEC

Investment focus

As listed in industry directories; may be out of date.

Stages
Series A
Geographies
USA

People(4)

Owners and executive officers named on the firm's SEC Form ADV.

Funds(8)

Private funds reported on Form ADV, with amounts raised from the funds' SEC Form D filings.

FundTypeGross assetsRaised (Form D)InvestorsLast Form DRecency
Atlas Venture Opportunity Fund III, L.P.Venture Capital$399.0M$400.0M84Sep 2025Cool
Atlas Venture Fund Xiv, L.P.Venture Capital$452.0M$450.0M84Dec 2024Cool
Atlas Venture Fund Xiii, L.P.Venture Capital$551.4M$450.0M87Mar 2022Cold
Atlas Venture Opportunity Fund II, L.P.Venture Capital$287.4M$300.0M69Oct 2021Cold
Atlas Venture Fund XII, L.P.Venture Capital$318.2M$400.0M85Jun 2020Cold
Atlas Venture Opportunity Fund I, L.P.Venture Capital$164.0M$250.0M47Jan 2019Cold
Atlas Venture Fund XI, L.P.Venture Capital$340.2M$350.0M70Jun 2017Cold
Atlas Venture Fund X, L.P.Venture Capital$490.8M——Dec 2014Cold

Board seats(9)

Companies whose SEC Form D filings name one of this firm's people as a director, matched by name and office ZIP code.

AVROBIO
BiotechnologyWatertown, MADirector: Bruce Booth
$253.0M raised
Since Aug 2016
SEC Form D
Judo Bio
BiotechnologyCambridge, MADirector: Kevin Bitterman
$55.0M raised
Since Nov 2022
SEC Form D
GRO Biosciences
Other TechnologyCambridge, MADirector: Kevin Bitterman
$33.3M raised
Since Jul 2024
SEC Form D
Matchpoint Therapeutics
PharmaceuticalsCambridge, MADirector: Bruce Booth
$42.0M raised
Since Oct 2022
SEC Form D
Vigil Neuroscience
PharmaceuticalsCambridge, MADirector: Bruce Booth
$215.0M raised
Since Oct 2020
SEC Form D
Lysosomal Therapeutics
BiotechnologyCambridge, MADirector: Bruce Booth
$38.0M raised
Since Feb 2015
SEC Form D
Magenta Therapeutics
BiotechnologyCambridge, MADirector: Bruce Booth
$116.0M raised
Since Nov 2016
SEC Form D
Rodin Therapeutics
Other Health CareCambridge, MADirector: Bruce Booth
$10.8M raised
Since Sep 2017
SEC Form D
Gemini Therapeutics
BiotechnologyCambridge, MADirector: Jason Rhodes
$2.0M raised
Since May 2016
SEC Form D

Shares boards with

Firms whose people sit on the same company boards.

Regulatory identifiers

CRD number
174766
SEC file number
802-81032

Sources